Table 3 Chemokine scores by presence or absence of SLE clinical features
Clinical features | SLE clinical features present | SLE clinical features absent | P | ||
|---|---|---|---|---|---|
| Â | n | Median (interquartile range) | n | Median (interquartile range) | Â |
Renal | 36 | 8.32 (1.43 to 19.41) | 31 | 3.39 (-1.43 to +12.48) | NS |
Neurological | 4 | 1.27 (-0.65 to +4.17) | 63 | 6.23 (-0.42 to +15.60) | NS |
Arthritis | 12 | 5.09 (-2.48 to +13.98) | 55 | 5.93 (0.12 to 14.01) | NS |
Serositis | 13 | 5.47 (0.67 to 38.08) | 54 | 5.32 (-0.93 to +13.96) | NS |
Rash | 22 | 2.37 (-2.27 to +13.96) | 45 | 7.39 (0.89 to 15.634) | NS |
Mucosal ulcer | 8 | 4.21 (1.95 to 14.33) | 59 | 5.93 (-4.46 to +14.01) | NS |
Haematological | 19 | 7.39 (-2.77 to +13.91) | 48 | 5.09 (0.59 to 14.81) | NS |
Proteinuria | 26 | 8.511 (2.01 to 23.25) | 41 | 3.39 (-1.56 to +12.56) | NS |
Autoantibodies | Â | Â | Â | Â | Â |
   Anti-dsDNA | 37 | 5.47 (-0.32 to +14.17) | 30 | 5.72 (-0.44 to +14.81) | NS |
   Anti-Ro | 24 | 6.05 (1.85 to 13.96) | 43 | 5.47 (-1.76 to +15.69) | NS |
   Anti-Sm | 13 | 11.56 (3.89 to 23.82) | 54 | 3.56 (-1.72 to +12.66) | 0.0211 |
   Anti-RNP | 23 | 10.28 (3.08 to 18.97) | 44 | 2.95 (-1.72 to +12.56) | 0.0212 |
   Anti-nucleosome | 24 | 7.50 (1.63 to 15.69) | 43 | 3.73 (-0.46 to +13.91) | NS |
Medical therapy | Â | Â | Â | Â | Â |
   Predisone dose >30 mg/day | 38 | 4.76 (-1.56 to +12.66) | 29 | 7.72 (2.12 to 19.89) | NS |
   Immunosuppressants | 28 | 9.98 (0.53 to 17.33) | 39 | 3.08 (-1.43 to +12.65) | NS |
   CQ/HCQ | 28 | 2.15 (-1.72 to +12.11) | 39 | 8.92 (2.34 to 18.97) | 0.0481 |